Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer - Oliver Hantschel, 2012
BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction | Encyclopedia MDPI
Role of ABL family kinases in cancer: from leukaemia to solid tumours | Nature Reviews Cancer
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell
Frontiers | c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson's Disease
IJMS | Free Full-Text | c-Abl Tyrosine Kinase Is Regulated Downstream of the Cytoskeletal Protein Synemin in Head and Neck Squamous Cell Carcinoma Radioresistance and DNA Repair
Cytoplasmic signalling by the c‐Abl tyrosine kinase in normal and cancer cells - Sirvent - 2008 - Biology of the Cell - Wiley Online Library
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
A Split-Abl Kinase for Direct Activation in Cells - ScienceDirect
Bcr-Abl阻害 | Bcr-Abl Inhibition
Conformational states dynamically populated by a kinase determine its function | Science
Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase: Cell
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
JCI - Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram
Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
